Christos Paliompeis
Director, Clinical Science @Summit Therapeutics, Inc.
Signup · Get unlimited contacts
WORK HISTORY
Director, Clinical Science @Summit Therapeutics, Inc.
Oxford, GB
Clinical Scientist — contributing to late-stage global oncology clinical development.• NCT06••••14: Randomized, double-blind, multiregional Phase study of ivonescimab versus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer in patients with high PD-L1 expression (HARMONi-7).• NCT05••••08: Randomized, double-blind, multiregional Phase study of ivonescimab combined with chemotherapy versus pembrolizumab combined with chemotherapy as first-line treatment for metastatic non-small cell lung cancer (HARMONi-3).
EDUCATION
University of Glasgow
Bachelor of Science Honours - BSc Hons, Molecular and Cellular Biology
Imperial College London
Master of Research - MRes, Clinical Research Design & Management
Imperial College London
Master of Science - MS, Molecular Medicine
University of Oxford
Master of Science - MS, Experimental and Translational Therapeutics
King's College London
Master of Science - MS, Clinical Pharmacology
ABOUT CHRISTOS PALIOMPEIS
I am a seasoned clinical scientist with over 17 years of experience in the pharmaceutical…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.